(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

VENERINASE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

VENERINASE

ST13

US500000090715336

Class

1, 5

Filing

90715336

Registration

7064829

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

28

Latest update

04/03/2026

Trademark type

Word

Nice classes

1, 5

Filing date

05/17/2021

Registration date

05/30/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/30/2023

Last transaction

04/03/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

16

Owner location

Milano (MI), IT

Examiner

FARRELL, ANNE M

Law office

M90

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Cristalfarma S.r.l.

Representatives

Francesco Braga PERANI & PARTNERS S.P.A.

Technical classification

Nice Classes

Class 1Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Chemical materials and chemical preparations and natural elementsplant extractsfor use in the manufacture of pharmaceuticals and phytopharmaceuticals; Chemical and organic compositions for use in the manufacture of food and beverageschemical additives for use in the manufacture of food and dietary supplements

Class 5

Medical preparations for the treatment of menopausal and perimenopausal disorders; Pharmaceuticals and natural remedy preparations for the well-being of womenpharmaceutical and medical preparations for the treatment of menopausal and perimenopausal disorders; Phytotherapy preparations for medical purposes; Medicinal healthcare preparations for the treatment of menopausal and perimenopausal disorders; Dietary and food supplements for humansfor the all-round psychophysical well-beingfor medical purposes; Dietetic substancesfood supplementsadapted for medical use

Publications

History of USPTO decisions and trademark events.

28 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/11/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/11/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/11/2026

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

03/11/2026

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

03/11/2026

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

05/30/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

05/30/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/14/2023

PUBO

PUBLISHED FOR OPPOSITION

03/14/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/22/2023

FIXD

ELECTRONIC RECORD REVIEW COMPLETE

02/06/2023

ERRR

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

02/03/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/28/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/13/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/13/2023

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

01/13/2023

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

07/22/2022

GNFR

FINAL REFUSAL E-MAILED

07/22/2022

CNFR

FINAL REFUSAL WRITTEN

07/22/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/22/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/22/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/22/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

12/27/2021

GNRT

NON-FINAL ACTION E-MAILED

12/27/2021

CNRT

NON-FINAL ACTION WRITTEN

12/27/2021

DOCK

ASSIGNED TO EXAMINER

12/14/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/14/2021

NWAP

NEW APPLICATION ENTERED

05/20/2021

Continuous trademark protection

Get notified about every new filing that threatens VENERINASE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.